GeneLink, Inc. (GNLKQ)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0001 - Volume
500 - Avg. Volume
0 - Market Cap (intraday)
397,528 - Beta (5Y Monthly) -159.06
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.
www.genelinkbio.comRecent News: GNLKQ
View MorePerformance Overview: GNLKQ
Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GNLKQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GNLKQ
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-141.05%
Return on Assets (ttm)
-69.12%
Return on Equity (ttm)
--
Revenue (ttm)
1.58M
Net Income Avi to Common (ttm)
-2.23M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
127.56k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.75M